Boston-based Grantham has cut about 10% of its 650-person staff, according to Bloomberg. The layoffs include nine stock and bond analysts. The firm's assets have fallen about 20% in the past two years, to $99 billion, according to Morningstar.
In addition to the layoffs, several members of top management are leaving Jeremy Grantham's GMO. David Cowen, head of global equity, and Chris Fortson, head of fundamental research in global equity, will leave GMO at the end of the month.
